AbbVie | ABBV - 借入資本

株価
205.07
毎日の変更
-1.16 -0.56%
毎月
-10.64%
毎年
-2.35%
Q1 予測
198.92




借入資本 変化する 日付
AbbVie USD 62.97B 12M 2025-09
Abbott USD 9.9B 1.7B 2025-12
ALKERMES USD 285.82M 639K 2024-09
Amgen USD 50B 2.43B 2025-12
AstraZeneca USD 26.14B 19.58B 2025-12
Biogen USD 6.29B 1.4M 2025-09
BioMarin Pharmaceutical USD 597.18M 513K 2025-12
Bristol-Myers Squibb USD 42.85B 1.62B 2025-12
Coherus Biosciences USD 51.08M 496K 2025-12
Eisai JPY 134.77B 12M 2025-12
Eli Lilly USD 40.87B 5.6M 2025-12
Gilead Sciences USD 22.14B 5M 2025-09
GlaxoSmithKline GBP 14.71B 186M 2025-12
Infinity Pharmaceuticals USD 0 0 2022-06
J&J USD 39.44B 30M 2025-12
Medtronic USD 27.88B 255M 2025-12
Merck USD 39.97B 6B 2025-09
Neurocrine Biosciences USD 169.5M 500K 2023-03
Novartis USD 29.59B 5.35B 2025-12
Pacira USD 372.19M 4.53M 2025-12
Perrigo USD 3.6B 4.5M 2025-12
Pfizer USD 57.41B 93M 2025-09
Regeneron Pharmaceuticals USD 2.71B 720.4M 2025-12
Roche Holding CHF 27.43B 966M 2025-12
Sanofi EUR 15.72B 2.45B 2025-12
UCB EUR 2.18B 634M 2025-12
Ultragenyx Pharmaceutical USD 763.74M 19.02M 2025-09
United Therapeutics USD 100M 100M 2024-06
Vertex Pharmaceuticals USD 111.4M 1.4M 2025-03
Zoetis USD 9.04B 1.97B 2025-12